Safety and efficacy of pharmacologic weight loss in patients with cirrhosis
Abstract Background Obesity poses unique risks in patients with advanced liver fibrosis; however, given surgical risks of bariatric surgery in cirrhosis treatment recommendations are currently limited to lifestyle interventions. This study seeks to inform a potential treatment gap by describing the...
Saved in:
Main Authors: | Ali Y. Fakhreddine (Author), Samantha Bagsic (Author), Ken Fujioka (Author), Catherine T. Frenette (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of health supplement for weight loss
by: Saliza Ibrahim, et al.
Published: (2016) -
Efficacy and Safety of Ascites Treatment in Liver Cirrhosis
by: G. A. Ignatenko, et al.
Published: (2022) -
Optimizing muscle preservation during weight loss in patients with cirrhosis: A pilot study comparing continuous energy restriction to alternate‐day modified fasting for weight loss in patients with obesity and non‐alcoholic cirrhosis of the liver
by: Winston Dunn, et al.
Published: (2024) -
Safety and Efficacy of Glucomannan for Weight Loss in Overweight and Moderately Obese Adults
by: Joyce K. Keithley, et al.
Published: (2013) -
Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy
by: Annie S. Hong, et al.
Published: (2022)